[HTML][HTML] In vivo thrombus formation
B Furie, BC Furie - Journal of Thrombosis and Haemostasis, 2007 - Elsevier
Thrombus formation, including platelet adhesion, activation, secretion and aggregation as
well as tissue factor-initiated thrombin generation and fibrin formation, has been studied in …
well as tissue factor-initiated thrombin generation and fibrin formation, has been studied in …
In vivo thrombus formation in murine models
UJH Sachs, B Nieswandt - Circulation research, 2007 - Am Heart Assoc
Platelets play a central role in hemostasis, but also in atherothrombosis, as they rapidly
adhere to tissue and to one another as a response to any vascular injury. This process …
adhere to tissue and to one another as a response to any vascular injury. This process …
[HTML][HTML] The tissue factor–factor VIIa complex: procoagulant activity, regulation, and multitasking
Greater understanding of the cellular interactions associated with tissue factor (TF), activated
factor (F) VII and TF–FVIIa complexes is likely to provide considerable clinical benefit. This …
factor (F) VII and TF–FVIIa complexes is likely to provide considerable clinical benefit. This …
Detection and measurement of microparticles: an evolving research tool for vascular biology
AK Enjeti, LF Lincz, M Seldon - Seminars in thrombosis and …, 2007 - thieme-connect.com
Microparticles are small, membrane-bound vesicles that are generated from cells of different
origin. It now appears that all circulating blood cells as well as endothelial cells release …
origin. It now appears that all circulating blood cells as well as endothelial cells release …
Signal transduction during platelet plug formation
LF Brass, TJ Stalker, L Zhu, DS Woulfe - Platelets, 2007 - books.google.com
How platelet activation begins, and the degree to which it is essential, depends in part on
where it occurs within the circulation and why. In the venous system, low flow rates and …
where it occurs within the circulation and why. In the venous system, low flow rates and …
Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreading
S Kulkarni, KJ Woollard, S Thomas… - Blood, The Journal …, 2007 - ashpublications.org
The ability of platelets to provide a highly reactive surface for the recruitment of other
platelets and leukocytes to sites of vascular injury is critical for hemostasis …
platelets and leukocytes to sites of vascular injury is critical for hemostasis …
P-selectin/PSGL-1 and other interactions between platelets, leukocytes, and endothelium
RP McEver - Platelets, 2007 - books.google.com
In response to hemorrhage, circulating platelets adhere to exposed subendothelial tissues
and then recruit additional platelets into aggregates that function as procoagulant surfaces …
and then recruit additional platelets into aggregates that function as procoagulant surfaces …
Microparticles adhere to collagen type I, fibrinogen, von Willebrand factor and surface immobilised platelets at physiological shear rates
JFW Keuren, EJP Magdeleyns… - British journal of …, 2007 - Wiley Online Library
Microparticles (MPs), shed during the storage of platelets, support blood coagulation and
could be helpful in restoring the haemostatic system in thrombocytopenic patients. The …
could be helpful in restoring the haemostatic system in thrombocytopenic patients. The …
Tissue factor: a mini‐review
V Daubie, R Pochet, S Houard… - Journal of tissue …, 2007 - Wiley Online Library
Tissue factor (TF) is historically known as the trigger of the coagulation cascade. This
integral membrane glycoprotein forms a ternary complex with factor VIIa (FVIIa) and …
integral membrane glycoprotein forms a ternary complex with factor VIIa (FVIIa) and …
Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot
Z Bagoly, G Haramura… - Thrombosis and …, 2007 - thieme-connect.com
Activated clotting factors are down-regulated by two major mechanisms which involve
protease inhibitors or proteolytic degradation. To date, no down-regulating mechanism for …
protease inhibitors or proteolytic degradation. To date, no down-regulating mechanism for …